FDA committee recommends updating COVID booster shots to include new variants
"We need a periodic update. Second, it’s time to move from the current bivalent to a monovalent vaccines."
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
"We need a periodic update. Second, it’s time to move from the current bivalent to a monovalent vaccines."
Roche, a Swiss multinational healthcare company, has unveiled a new test for targeting the fast-spreading XBB.1.5 Omicron sub-variant.